Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Cronos Group Inc. Common Share (CRON) has a market cap of $974.16M with year-over-year revenue growth of +34.8%. Net margin stands at 34.9%. The stock trades at a P/E ratio of 23.7.
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, CRON posted revenue growth of +34.8% and trades at a P/E of 23.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.